|
Venture Capital Law in China
Hardback
Main Details
Description
China's venture capital market is not just the world's largest and fastest developing market, it also has the unique distinction of being engineered through heavy governmental intervention. This book breaks new ground by examining and testing established legal theories regarding the law of venture capital through the lens of the Chinese venture capital market. Using a hand-collected dataset of venture capital agreements, interviews with practitioners, and Chinese court judgements, it provides a comprehensive and insightful analysis of the Chinese venture capital market from the legal perspective. Topics covered include the roles of law and governmental intervention in developing the market, the state of investor protection, unique contractual developments and exits of venture capital investments. By providing an in-depth comparative analysis against the American venture capital market, it provides critical context and makes the Chinese venture market accessible. It is an invaluable resource for venture capital scholars, policymakers and practitioners.
Author Biography
Lin Lin is an Assistant Professor at the Faculty of Law, National University of Singapore. She specializes in corporate law, corporate finance, alternative investments and Chinese corporate law. She has held visiting appointments at Stanford, Oxford and Melbourne. She practised corporate and securities law prior to entering academia.
Reviews'China's venture capital industry has grown explosively over the last decade and today rivals that of the United States in its influence and performance. But the complex workings of this sector remain poorly understood, including by many seasoned venture capitalists. This book provides a clear, informative and insightful exploration of the evolving structure and organization of Chinese venture funds, a sector that will be critical to the future of innovation domestically and globally.' Josh Lerner, Professor of Investment Banking, Head of Entrepreneurial Management, Harvard Business School
|